Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene

Steroids

Volumn 73, Issue 1, 2008, Pages 139-147

  Starlard Davenport, Athena ^a   Lyn Cook, Beverly ^b   Radominska Pandya, Anna ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Breast cancer; Estradiol (E2); Estrogen receptor (ER); UGT1A10; UGTs

Indexed keywords

DACTINOMYCIN; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; GENISTEIN; GLUCURONOSYLTRANSFERASE 1A10; MESSENGER RNA; PROPYLPYRAZOLETRIOL; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; ESTROGEN ACTIVITY; GENE; GENE CONTROL; GENE IDENTIFICATION; GENE INACTIVATION; GENE INDUCTION; GLUCURONIDATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UGT1A10 GENE; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; GLUCURONOSYLTRANSFERASE; HUMANS; PYRAZOLES; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 37049018023     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.09.007     Document Type: Article

References (38)

1. Porter J.C. Proceedings: hormonal regulation of breast development and activity. J Invest Dermatol 63 (1974) 85-92
2. Keen J.C., and Davidson N.E. The biology of breast carcinoma. Cancer 97 (2003) 825-833
3. MacGregor J.I., and Jordan V.C. Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 50 (1998) 151-196
4. Tsuchiya M., Nakao H., Katoh T., Sasaki H., Hiroshima M., Tanaka T., et al. Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19. Hum Reprod 20 (2005) 974-978
5. McEwen B.S., and Alves S.E. Estrogen actions in the central nervous system. Endocr Rev 20 (1999) 279-307
6. Klinge C.M. Estrogen receptor interaction with co-activators and co-repressors. Steroids 65 (2000) 227-251
7. McKenna N.J., and O'Malley B.W. From ligand to response: generating diversity in nuclear receptor coregulator function. J Steroid Biochem Mol Biol 74 (2000) 351-356
8. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C., and Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264 (1994) 1455-1458
9. Radominska-Pandya A., Czernik P.J., Little J.M., Jude A.R., Tephly T.R., and Carter C.A. Identification of the recombinant UDP-glucuronosyltransferase 2B7 in nuclear envelopes. DMW/ISSX Meeting 2000. St. Andrews, Fife, Scotland, June 11-16, 2000 (2000)
10. Dutton G.J. Glucuronidation of drugs and other compounds (1980), CRC Press Inc., Boca Raton, FL
11. Bock K.W., Lilienblum W., Fischer G., Schirmer G., and Bock-Henning B.S. The role of conjugation reactions in detoxication. Arch Toxicol 60 (1987) 22-29
12. Coffman B.L., King C.D., Rios G.R., and Tephly T.R. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos 26 (1998) 73-77
13. Formelli F., Barua A.B., and Olson J.A. Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl beta-glucuronide. FASEB J 10 (1996) 1014-1024
14. Vore M., Montgomery C., and Meyers M. Steroid D-ring glucuronides: characterization of a new class of cholestatic agents. Drug Metab Rev 14 (1983) 1005-1019
15. Oelberg D.G., Chari M.V., Little J.M., Adcock E.W., and Lester R. Lithocholate glucuronide is a cholestatic agent. J Clin Invest 73 (1984) 1507-1514
16. Kroemer H.K., and Klotz U. Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 23 (1992) 292-310
17. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Belanger A., et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7 (1997) 255-269
18. Gong Q.H., Cho J.W., Huang T., Potter C., Gholami N., Basu N.K., et al. Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11 (2001) 357-368
19. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40 (2000) 581-616
20. Mackenzie P.I., Miners J.O., and McKinnon R.A. Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance. Clin Chem Lab Med 38 (2000) 889-892
21. King C.D., Rios G.R., Green M.D., and Tephly T.R. UDP-glucuronosyltransferases. Curr Drug Metab 1 (2000) 143-161
22. Radominska-Pandya A., Pokrovskaya I.D., Xu J., Little J.M., Jude A.R., Kurten R.C., et al. Nuclear UDP-glucuronosyltransferases: identification of UGT2B7 and UGT1A6 in human liver nuclear membranes. Arch Biochem Biophys 399 (2002) 37-48
23. Starlard-Davenport A., Xiong Y., Bratton S., Gallus-Zawada A., Finel M., and Radominska-Pandya A. Phenylalanine(90) and phenylalanine(93) are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10. Steroids 72 (2007) 85-94
24. Basu N.K., Kubota S., Meselhy M.R., Ciotti M., Chowdhury B., Hartori M., et al. Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation. J Biol Chem 279 (2004) 28320-28329
25. Lewinsky R.H., Smith P.A., and Mackenzie P.I. Glucuronidation of bioflavonoids by human UGT1A10: structure-function relationships. Xenobiotica 35 (2005) 117-129
26. Strassburg C.P., Manns M.P., and Tukey R.H. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 273 (1998) 8719-8726
27. Congiu M., Mashford M.L., Slavin J.L., and Desmond P.V. UDP glucuronosyltransferase mRNA levels in human liver disease. Drug Metab Dispos 30 2 (2002) 129-134
28. Paul P., Lutz T.M., Osborn C., Kyosseva S., Elbein A.D., Towbin H., et al. Synthesis and characterization of a new class of inhibitors of membrane-associated UDP-glycosyltransferases. J Biol Chem 268 (1993) 12933-12938
29. Little J.M., Williams L., Xu J., and Radominska-Pandya A. Glucuronidation of the dietary fatty acids, phytanic acid and docosahexaenoic acid, by human UDP-glucuronosyltransferases. Drug Metab Dispos 30 (2002) 531-533
30. Harrington W.R., Sengupta S., and Katzenellenbogen B.S. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. Endocrinology 147 (2006) 3843-3850
31. Stauffer S.R., Coletta C.J., Tedesco R., Nishiguchi G., Carlson K., Sun J., et al. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem 43 (2000) 4934-4947
32. Raftogianis R., Creveling C., Weinshilboum R., and Weisz J. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr (2000) 113-124
33. Basu N.K., Ciotti M., Hwang M.S., Kole L., Mitra P.S., Cho J.W., and Owens I.S. Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake. J Biol Chem 279 (2004) 1429-1441
34. Guillemette C., Levesque E., Beaulieu M., Turgeon D., Hum D.W., and Belanger A. Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology 138 (1997) 2998-3005
35. Yang C., Yu B., Zhou D., and Chen S. Regulation of aromatase promoter activity in human breast tissue by nuclear receptors. Oncogene 21 (2002) 2854-2863
36. Dobrzycka K.M., Townson S.M., Jiang S., and Oesterreich S. Estrogen receptor corepressors-a role in human breast cancer?. Endocr Relat Cancer 10 (2003) 517-536
37. Anderson I., and Gorski J. Estrogen receptor alpha interaction with estrogen response element half-sites from the rat prolactin gene. Biochemistry 39 (2000) 3842-3847
38. Das D., Peterson R.C., and Scovell W.M. High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity. Mol Endocrinol 18 (2004) 2616-2632